Translating MicroRNA discovery into clinical biomarkers in cancer.

[1]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[2]  S. Waldman,et al.  Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation , 2007, Clinical pharmacology and therapeutics.

[3]  A. Terzic,et al.  Clinical pharmacology: the science of therapeutics , 2007, Clinical pharmacology and therapeutics.

[4]  J. Wagner,et al.  Biomarkers and Surrogate End Points for Fit‐for‐Purpose Development and Regulatory Evaluation of New Drugs , 2007, Clinical pharmacology and therapeutics.

[5]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[6]  John A. Wagner,et al.  A cost-effectiveness approach to the qualification and acceptance of biomarkers , 2006, Nature Reviews Drug Discovery.

[7]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[8]  Stefano Volinia,et al.  MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  K. Hudson.  Genetic Testing Oversight , 2006, Science.

[10]  J. Wilson.  The rocky road to useful cancer biomarkers. , 2006, Annals of internal medicine.

[11]  S. Friend,et al.  Cancer Biomarkers—An Invitation to the Table , 2006, Science.

[12]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[13]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[14]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[15]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[18]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[19]  B. Harfe,et al.  MicroRNAs in vertebrate development. , 2005, Current opinion in genetics & development.

[20]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[21]  John Bracht,et al.  MicroRNAs: a developing story. , 2005, Current opinion in genetics & development.

[22]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[23]  C. Croce,et al.  An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[25]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.